Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market to Reach $4.2 Billion by 2027

·26 min read

Abstract: - Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market to Reach $4. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Real-time PCR (qPCR) and Digital PCR (dPCR) estimated at US$2.

New York, June 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Real-time PCR (qPCR) and Digital PCR (dPCR) Industry" - https://www.reportlinker.com/p06032742/?utm_source=GNW
6 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at aCAGR of 7.2% over the period 2020-2027. Quantitative, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Digital segment is readjusted to a revised 12.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $694 Million, While China is Forecast to Grow at 11% CAGR
- The Real-time PCR (qPCR) and Digital PCR (dPCR) market in the U.S. is estimated at US$694 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$921.8 Million by the year 2027 trailing a CAGR of 10.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

- Select Competitors (Total 32 Featured) -

  • Abbott Laboratories

  • Agilent Technologies, Inc.

  • Analytik Jena AG

  • Becton Dickinson and Company

  • Bio Molecular Systems

  • Biomeme Inc.

  • Biomérieux S.A.

  • Bioneer Corporation

  • Bio-Rad Laboratories, Inc.

  • Cole-Parmer Instrument Company Llc

  • Danaher Corporation

  • Elitech Group Sas

  • Enzo Life Sciences, Inc.

  • Eppendorf AG

  • F. Hoffman-La Roche Ltd.

  • Fluidigm Corporation

  • JN Medsys

  • Merck KGaA

  • Meridian Bioscience, Inc.

  • Promega Corporation

  • Qiagen N.V.

  • Quanta Biosciences Inc.

  • Sacace Biotechnologies Srl

  • Takara Bio, Inc.

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p06032742/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Quantitative by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Quantitative by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Quantitative by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Digital by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Digital by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Digital by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Consumables &
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Consumables & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Consumables & Reagents
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Software &
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Software & Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Research by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Research by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Clinical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Clinical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Clinical by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 31: USA Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 32: USA Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 33: USA 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Percentage Breakdown of
Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 35: USA Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 40: Canada Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 41: Canada Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 42: Canada 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 44: Canada Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 48: Japan 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 49: Japan Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 50: Japan Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 51: Japan 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 53: Japan Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 57: China 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 58: China Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 59: China Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 60: China 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 62: China Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 70: Europe Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 71: Europe Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 72: Europe 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 74: Europe Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 79: France Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 80: France Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 81: France 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 83: France Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 88: Germany Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 89: Germany Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 90: Germany 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 92: Germany Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 96: Italy 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 97: Italy Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 98: Italy Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 99: Italy 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 101: Italy Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 105: UK 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 106: UK Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 107: UK Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 108: UK 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Percentage Breakdown of
Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 110: UK Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

SPAIN
Table 112: Spain Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 114: Spain 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 115: Spain Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 116: Spain Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 117: Spain 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 118: Spain Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 119: Spain Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 120: Spain 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

RUSSIA
Table 121: Russia Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Technology - Quantitative and
Digital - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 122: Russia Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Technology - Quantitative and Digital
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 123: Russia 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Technology - Percentage Breakdown of
Value Sales for Quantitative and Digital for the Years 2012,
2020 & 2027

Table 124: Russia Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Product Type - Consumables &
Reagents, Instruments and Software & Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 125: Russia Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Product Type - Consumables & Reagents,
Instruments and Software & Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 126: Russia 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Product Type - Percentage Breakdown
of Value Sales for Consumables & Reagents, Instruments and
Software & Services for the Years 2012, 2020 & 2027

Table 127: Russia Current & Future Analysis for Real-time PCR
(qPCR) and Digital PCR (dPCR) by Application - Research,
Clinical and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 128: Russia Historic Review for Real-time PCR (qPCR) and
Digital PCR (dPCR) by Application - Research, Clinical and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 129: Russia 15-Year Perspective for Real-time PCR (qPCR)
and Digital PCR (dPCR) by Application - Percentage Breakdown of
Value Sales for Research, Clinical and Other Applications for
the Years 2012, 2020 & 2027

REST OF EUROPE
Table 130: Rest of Europe Current & Future Analysis for
Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology -

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032742/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting